- Trials with a EudraCT protocol (43,122)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
43,122 result(s) found.
Displaying page 1,786 of 2,157.
EudraCT Number: 2016-004038-24 | Sponsor Protocol Number: 120012A | Start Date*: 2018-01-12 | |||||||||||
Sponsor Name:Modern Biosciences plc | |||||||||||||
Full Title: A 12-Week, Double-Blind, Placebo-Controlled, Phase 2a Study to Investigate the Safety, Tolerability and Efficacy of MBS2320 in Patients with Active Rheumatoid Arthritis receiving Methotrexate | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: RO (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000501-23 | Sponsor Protocol Number: B7451014 | Start Date*: 2018-10-16 | |||||||||||
Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A phase 3 randomized withdrawal, double-blind, placebo-controlled, multi-center study investigating the efficacy and safety of PF-04965842 in subjects aged 12 years and over, with moderate to seve... | |||||||||||||
Medical condition: Moderate to severe atopic dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) NL (Completed) BE (Completed) PL (Completed) DE (Completed) LV (Completed) SK (Completed) ES (Completed) IT (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-000243-80 | Sponsor Protocol Number: MSV_LE | Start Date*: 2022-05-26 | |||||||||||
Sponsor Name:Hospital Universitario Rio Hortega | |||||||||||||
Full Title: PHASE II, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF MESENCHYMAL CELLS (MSV-allo®) IN THE TREATMENT OF LUPUS NEPHRITIS. | |||||||||||||
Medical condition: Lupus nephritis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000615-31 | Sponsor Protocol Number: DIA-EC-Cupa1-01-22 | Start Date*: 2022-05-26 | |||||||||||
Sponsor Name:Diater Laboratorio de Diagnósticos y Aplicaciones Terapéuticas | |||||||||||||
Full Title: Multicenter, double-blind, randomized, placebo-controlled phase III clinical trial in parallel groups which evaluates the clinical efficacy and safety of immunotherapy with the purified major aller... | |||||||||||||
Medical condition: Allergic patients to the Cupressaceae pollen with moderate/severe allergic rhino conjunctivitis with or without controlled asthma | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006410-36 | Sponsor Protocol Number: BORT-112 | Start Date*: 2022-05-26 | ||||||||||||||||||||||||||
Sponsor Name:Clínica Universidad Navarra | ||||||||||||||||||||||||||||
Full Title: Phase Ib/II open-label clinical study of intratumoral administration of BO-112 in combination with radiotherapy and nivolumab in patients with metastatic PD-1/PDL-1 refractory non-small cell lung c... | ||||||||||||||||||||||||||||
Medical condition: Metastatic PD-1/PDL-1 refractory non-small-cell lung cancer | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002337-30 | Sponsor Protocol Number: B7921005 | Start Date*: 2017-04-11 | |||||||||||
Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A 12 WEEK RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, PARALLEL GROUP, ACTIVE AND PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY PROFILE OF PF-06650833 IN SUBJECTS WITH ACTIVE R... | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) DE (Completed) HU (Completed) CZ (Completed) SK (Completed) ES (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005599-51 | Sponsor Protocol Number: CD101.IV.2.03 | Start Date*: 2016-09-26 | |||||||||||
Sponsor Name:Cidara Therapeutics Inc. | |||||||||||||
Full Title: A Phase 2, Multicenter, Randomized, Double-blind Study of the Safety, Tolerability, and Efficacy of CD101 Injection vs Intravenous Caspofungin Followed By Oral Fluconazole Step-down in the Treatmen... | |||||||||||||
Medical condition: Candidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) GR (Completed) HU (Completed) BG (Completed) BE (Completed) IT (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001734-36 | Sponsor Protocol Number: DR200111 | Start Date*: 2020-04-20 |
Sponsor Name:CHRU de TOURS | ||
Full Title: Efficacy and safety of ANAkinra during Adult « COVID-19 » with Aggravating respiratory symptoms: a multicenter open-label controlled randomized trial | ||
Medical condition: COVID-19 infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-020783-38 | Sponsor Protocol Number: VB-201-030 | Start Date*: 2010-09-29 |
Sponsor Name:Vascular Biogenics Ltd | ||
Full Title: A Phase II, Randomised, Double blind, Placebo-Controlled, Dose-Ranging Study to Assess the Effect of Multiple Doses of VB-201 on Biomarkers of Inflammation, Safety and Pharmacokinetics in Subjects ... | ||
Medical condition: elevated hsCRP and other biomarkers for inflammation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-004023-38 | Sponsor Protocol Number: GLC0107 | Start Date*: 2007-07-30 | |||||||||||
Sponsor Name:IRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS | |||||||||||||
Full Title: Prospective, multicentric, double-masked clinical study to compare the efficacy and safety of Ganfort and Duotrav in primary open angle and pseudoexfoliative glaucoma patients previously treated wi... | |||||||||||||
Medical condition: Glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) AT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000021-57 | Sponsor Protocol Number: 01000 | Start Date*: 2006-03-10 |
Sponsor Name:Rigshospitalet | ||
Full Title: Bosentan and Sildenfil for patients with Eisenmenger syndrome | ||
Medical condition: Eisenmengers syndrome is condition with severe pulmonary arterial hypertension due to a shunting of blood from the left side of the heart to the right side of the heart. When the pressure in the pu... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001743-31 | Sponsor Protocol Number: 18-03/MPA-M | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Dermapharm AG | |||||||||||||
Full Title: Double-blind, randomised clinical study comparing efficacy and safety of Methylprednisolone Aceponate 0.1% Cutaneous emulsion (Test) vs. Advantan Milk 0.1% Cutaneous emulsion (Reference) vs. Vehicl... | |||||||||||||
Medical condition: Atopic dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003557-24 | Sponsor Protocol Number: 400-12-004 | Start Date*: 2014-04-02 |
Sponsor Name:Ethicon Inc | ||
Full Title: A Prospective, Randomised, Controlled, Study Evaluating the Safety and Effectiveness of EVARREST® Sealant Matrix in Controlling Mild or Moderate Hepatic Parenchyma or Soft Tissue Bleeding During O... | ||
Medical condition: Mild or moderate hepatic parenchyma or soft tissue bleeding during open, abdominal, retroperitoneal, pelvic and thoracic (non-cardiac) surgery | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-006235-31 | Sponsor Protocol Number: RET 03.07 | Start Date*: 2007-09-13 | |||||||||||
Sponsor Name:IRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS | |||||||||||||
Full Title: 12 MONTHS CASE SERIES OPEN STUDY TO ASSESS THE SAFETY AND EFFICACY OF INTRAVITREAL INJECTION OF LUCENTIS (RANIBIZUMAB 0.5 MG) USED IN COMBINATION WITH VISUDYNE (VERTEPORFIN PDT) IN NAIVE SIBJECTS W... | |||||||||||||
Medical condition: subfoveal choroidal neovascularization secondary to age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002761-63 | Sponsor Protocol Number: HPV-301 | Start Date*: 2018-04-16 | ||||||||||||||||
Sponsor Name:Inovio Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR H... | ||||||||||||||||||
Medical condition: HPV-16 AND/OR HPV-18 RELATED HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (HSIL) OF THE CERVIX | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) LT (Completed) FI (Completed) DE (Completed) CZ (Prematurely Ended) ES (Completed) PT (Ongoing) PL (Completed) SK (Completed) BE (Completed) NL (Ongoing) EE (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-001499-20 | Sponsor Protocol Number: RV-MM-GMSG-392 | Start Date*: 2014-09-30 | |||||||||||
Sponsor Name:Meletios-Athanasios Dimopoulos | |||||||||||||
Full Title: A phase II open label, non comparative, non randomized study for the assessment of the efficacy and safety of lenalidomide + adriamycine and low dose dexamethasone combination (RAD) in newly diagno... | |||||||||||||
Medical condition: Newly Diagnosed multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001629-41 | Sponsor Protocol Number: DSC/15/2357/53 | Start Date*: 2018-11-15 | |||||||||||
Sponsor Name:ITALFARMACO S.P.A. | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled study to evaluate the micro-macroscopic effects on muscles, the safety and tolerability, and the efficacy of givinostat in patients with Becker Muscu... | |||||||||||||
Medical condition: Distrofia Muscolare di Becker (DMB) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: NL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005194-37 | Sponsor Protocol Number: CT-ORZY-NPC-001 | Start Date*: 2015-10-19 | |||||||||||
Sponsor Name:Orphazyme ApS | |||||||||||||
Full Title: A prospective non-therapeutic study in patients diagnosed with Niemann-Pick disease type C in order to characterise the individual patient disease profile and historic signo-symptomatology progress... | |||||||||||||
Medical condition: Niemann-Pick disease - type C | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002442-45 | Sponsor Protocol Number: AXAFA-AFNET5 | Start Date*: Information not available in EudraCT | ||||||||||||||||||||||||||
Sponsor Name:Kompetenznetz Vorhofflimmern e.V. [Atrial Fibrillation NETwork (AFNET)] | ||||||||||||||||||||||||||||
Full Title: Anticoagulation using the direct factor Xa inhibitor apixaban during Atrial Fibrillation catheter Ablation: Comparison to vitamin K antagonist therapy. | ||||||||||||||||||||||||||||
Medical condition: Atrial fibrillation catheter ablation | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Completed) BE (Completed) DK (Completed) GB (Completed) NL (Completed) ES (Completed) AT (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000859-91 | Sponsor Protocol Number: PHRI13-JM-LYRITUX | Start Date*: 2014-10-03 | |||||||||||
Sponsor Name:CHRU de TOURS | |||||||||||||
Full Title: Relation entre la déplétion des LYmphocytes T et la réponse clinique au RITUximab dans la polyarthrite rhumatoïde. | |||||||||||||
Medical condition: Cette étude portera donc sur une population de patients atteints de polyarthrite rhumatoïde (PR) actives et ayant présenté un échec ou une contre-indication à au moins un anti-TNFα, et n’ayant jama... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
